Both in Pharmaceuticals
Annexon vs Arbutus Biopharma
Over the past year ANNX returned +27.8% and ABUS returned −8.1%; their daily moves had a correlation of 0.29.
ANNX +27.8% ABUS −8.1%Growth of $1, one year, split-adjusted
| Metric | ANNX | ABUS |
|---|---|---|
| Price | $4.05 | $4.21 |
| Market cap | $767.8M | $834.0M |
| Today | +1.00% | −1.64% |
| 1 month | −1.7% | −7.7% |
| 6 months | −29.6% | −2.5% |
| Year to date | −19.3% | −12.5% |
| 1 year | +27.0% | −8.7% |
| Revenue growth (YoY) | — | −90.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −512.0% |
| P/E (TTM) | — | 5.5× |
| Price / sales | — | 4.6× |
| Net cash | $209.2M | $89.5M |
| Dividend yield | — | — |
| Volatility (60d) | 62.5% | 35.6% |
| Short % of float | 20.6% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).